Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
CC transcript
|
|
Molecular Insight Pharmaceuticals, Inc. (MIPI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/28/2011 |
4
| Barlow David S (10% Owner) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 12/20/2010 |
4
| Barlow David S (10% Owner) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/17/2010 |
4
| Stylli Harry (Director) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/17/2010 |
4
| STERLING LIONEL N (Director) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/17/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/17/2010 |
4
| LIMBER JOSEPH M (Director) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.85, valued at
$46.3k
|
|
| 05/17/2010 |
4
| Gottlieb Scott (Director) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/17/2010 |
4
| FRANK DANIEL (Director) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 01/21/2010 |
4
| Barlow David S (10% Owner) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 12/28/2009 |
4
| Barlow David S (10% Owner) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 12/28/2009 |
4
| Barlow David S (10% Owner) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 11/18/2009 |
4
| Abdalian Charles H Jr (VP of Finance and CFO) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 08/13/2009 |
4
| PETERS DANIEL (President and CEO) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 08/12/2009 |
4
| Babich John W (Exec. VP, CSO and Pres. of R&D) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 08/12/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 06/01/2009 |
4
| Gottlieb Scott (Director) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/29/2009 |
4
| LaFrance Norman D. (Sr. VP Clinical Dev and CMO) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/26/2009 |
4
| Wallroth Donald E. (CFO) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/14/2009 |
4
| Looney Paul Anthony (COO) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/14/2009 |
4
| Babich John W (President, CEO and CSO) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/14/2009 |
4
| STERLING LIONEL N (Director) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/14/2009 |
4
| Gottlieb Scott (Director) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/14/2009 |
4
| STACK DAVID M (Director) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/14/2009 |
4
| Stylli Harry (Director) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/14/2009 |
4
| FRANK DANIEL (Director) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/14/2009 |
4
| Kronauge James F (VP Process Chemistry) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/14/2009 |
4
| Barrett John A (Sr. V.P. of Preclinical Dev) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/14/2009 |
4
| Wallroth Donald E. (CFO) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/14/2009 |
4
| LaFrance Norman D. (Sr. VP Clinical Dev and CMO) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/14/2009 |
4
| Wachholz James (VP Reg. Affairs & Qual. Assur.) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 12/31/2008 |
4
| Barlow David S (10% Owner) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
|
|